Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Epic Sciences
3119
Epic Sciences
Technology
Biotechnology
Developing new diagnostic blood tests that can identify and characterize circulating tumor cells to improve cancer detection and to personalize medicine.
Suggest edits
Founded
2008
Raised
$150M
Follow us
Companies in the same industry
Ark Biosciences
Stemirna Therapeutics
Daye
Flux Bioscience
Metis Precision Medicine
ArsenalBio
Pathios Therapeutics
Kyverna Therapeutics
Ikarovec
Novadip Biosciences
Alexa global traffic share
Twitter followers
Overview
Funding
5
Add info
Latest funding
Show all
$52,000,000
Venture capital (Series E) - 2018
$40,000,000
Venture capital (Series D) - 2017
Domain Associates
Genomic Health
Sabby Capital
+6
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$52,000,000
Venture capital (Series E)
FinSMEs
,
PE HUB
,
MedCity News
Epic Sciences Closes $52M in Series E Financing
Health
Funding
Xconomy
Epic Sciences Advances Diagnostic for Late-Stage Prostate Cancer
Health
Science
Funding
$40,000,000
Venture capital (Series D)
PE HUB
Epic Sciences takes in $40 mln Series D
Funding
Messaging
